rs3828609

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000504875.5(CSF1R):​n.*1509A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.155 in 232,418 control chromosomes in the GnomAD database, including 3,217 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.16 ( 2275 hom., cov: 32)
Exomes 𝑓: 0.15 ( 942 hom. )

Consequence

CSF1R
ENST00000504875.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 2.27

Publications

12 publications found
Variant links:
Genes affected
CSF1R (HGNC:2433): (colony stimulating factor 1 receptor) The protein encoded by this gene is the receptor for colony stimulating factor 1, a cytokine which controls the production, differentiation, and function of macrophages. This receptor mediates most if not all of the biological effects of this cytokine. Ligand binding activates the receptor kinase through a process of oligomerization and transphosphorylation. The encoded protein is a tyrosine kinase transmembrane receptor and member of the CSF1/PDGF receptor family of tyrosine-protein kinases. Mutations in this gene have been associated with a predisposition to myeloid malignancy. The first intron of this gene contains a transcriptionally inactive ribosomal protein L7 processed pseudogene oriented in the opposite direction. Alternative splicing results in multiple transcript variants. Expression of a splice variant from an LTR promoter has been found in Hodgkin lymphoma (HL), HL cell lines and anaplastic large cell lymphoma. [provided by RefSeq, Mar 2017]
HMGXB3 (HGNC:28982): (HMG-box containing 3) This gene is one of the non-canonical high mobility group (HMG) genes. The encoded protein contains an HMG-box domain found in DNA binding proteins such as transcription factors and chromosomal proteins. [provided by RefSeq, Aug 2011]
HMGXB3 Gene-Disease associations (from GenCC):
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 5-150053300-T-C is Benign according to our data. Variant chr5-150053300-T-C is described in ClinVar as Benign. ClinVar VariationId is 352100.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CSF1RNM_001288705.3 linkc.*769A>G 3_prime_UTR_variant Exon 21 of 21 ENST00000675795.1 NP_001275634.1
HMGXB3NM_014983.3 linkc.*1108T>C downstream_gene_variant ENST00000502717.6 NP_055798.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CSF1RENST00000675795.1 linkc.*769A>G 3_prime_UTR_variant Exon 21 of 21 NM_001288705.3 ENSP00000501699.1
HMGXB3ENST00000502717.6 linkc.*1108T>C downstream_gene_variant 1 NM_014983.3 ENSP00000421917.1

Frequencies

GnomAD3 genomes
AF:
0.160
AC:
24302
AN:
152034
Hom.:
2279
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.210
Gnomad AMI
AF:
0.133
Gnomad AMR
AF:
0.287
Gnomad ASJ
AF:
0.177
Gnomad EAS
AF:
0.146
Gnomad SAS
AF:
0.0506
Gnomad FIN
AF:
0.0878
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.119
Gnomad OTH
AF:
0.184
GnomAD4 exome
AF:
0.147
AC:
11835
AN:
80266
Hom.:
942
Cov.:
0
AF XY:
0.148
AC XY:
5457
AN XY:
36984
show subpopulations
African (AFR)
AF:
0.214
AC:
814
AN:
3796
American (AMR)
AF:
0.299
AC:
733
AN:
2452
Ashkenazi Jewish (ASJ)
AF:
0.177
AC:
889
AN:
5036
East Asian (EAS)
AF:
0.164
AC:
1853
AN:
11272
South Asian (SAS)
AF:
0.0501
AC:
35
AN:
698
European-Finnish (FIN)
AF:
0.106
AC:
52
AN:
492
Middle Eastern (MID)
AF:
0.215
AC:
105
AN:
488
European-Non Finnish (NFE)
AF:
0.128
AC:
6318
AN:
49346
Other (OTH)
AF:
0.155
AC:
1036
AN:
6686
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
487
974
1462
1949
2436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.160
AC:
24298
AN:
152152
Hom.:
2275
Cov.:
32
AF XY:
0.159
AC XY:
11809
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.210
AC:
8693
AN:
41486
American (AMR)
AF:
0.287
AC:
4387
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.177
AC:
614
AN:
3468
East Asian (EAS)
AF:
0.146
AC:
754
AN:
5176
South Asian (SAS)
AF:
0.0496
AC:
239
AN:
4816
European-Finnish (FIN)
AF:
0.0878
AC:
930
AN:
10588
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.119
AC:
8112
AN:
67998
Other (OTH)
AF:
0.181
AC:
383
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1024
2048
3071
4095
5119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
246
492
738
984
1230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.134
Hom.:
4974
Bravo
AF:
0.183
Asia WGS
AF:
0.110
AC:
385
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary diffuse leukoencephalopathy with spheroids Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
13
DANN
Benign
0.71
PhyloP100
2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3828609; hg19: chr5-149432863; COSMIC: COSV53841175; COSMIC: COSV53841175; API